← Back to Discover
Catalio Capital Management, LP
Period ended Sep 30, 2026 · Latest filing Nov 16, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2026: $538,308,196
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- AVALYN PHARMACEUTICALS INC · COM SHS · 05348Y105 · shares: $48,400,265
- BRISTOL-MYERS SQUIBB CO · COM · 110122108 · shares: $31,182,278
- BRIDGEBIO PHARMA INC · COM · 10806X102 · shares: $27,972,304
- PARABILIS MEDICINES INC · COM · 698955101 · shares: $26,608,348
- JOHNSON & JOHNSON · COM · 478160104 · shares: $26,340,571
- ASCENDIS PHARMA A/S · ORD SHS · K08588103 · shares: $23,112,214
- ARROWHEAD PHARMACEUTICALS IN · COM · 04280A100 · shares: $20,632,916
- SYNDAX PHARMACEUTICALS INC · COM · 87164F105 · shares: $19,241,988
- DEFINIUM THERAPEUTICS INC · COM SHS · 24477V105 · shares: $18,952,510
- CELCUITY INC · COM · 15102K100 · shares: $18,338,028
Reported holdings
47 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| AVALYN PHARMACEUTICALS INC | COM SHS | 05348Y105 | — | 1,698,851 shares | $48,400,265 |
| BRISTOL-MYERS SQUIBB CO | COM | 110122108 | — | 499,716 shares | $31,182,278 |
| BRIDGEBIO PHARMA INC | COM | 10806X102 | — | 425,111 shares | $27,972,304 |
| PARABILIS MEDICINES INC | COM | 698955101 | — | 824,043 shares | $26,608,348 |
| JOHNSON & JOHNSON | COM | 478160104 | — | 99,496 shares | $26,340,571 |
| ASCENDIS PHARMA A/S | ORD SHS | K08588103 | — | 101,445 shares | $23,112,214 |
| ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | — | 315,247 shares | $20,632,916 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 1,023,510 shares | $19,241,988 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 497,964 shares | $18,952,510 |
| CELCUITY INC | COM | 15102K100 | — | 230,609 shares | $18,338,028 |
| SEPTERNA INC | COM | 81734D104 | — | 454,015 shares | $17,765,607 |
| GUARDANT HEALTH INC | COM | 40131M109 | — | 92,579 shares | $16,512,390 |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | — | 112,418 shares | $15,838,572 |
| 10X GENOMICS INC | CL A COM | 88025U109 | — | 164,029 shares | $14,821,660 |
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | — | 505,882 shares | $14,721,166 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 583,364 shares | $14,659,937 |
| EDWARDS LIFESCIENCES CORP | COM | 28176E108 | — | 161,121 shares | $13,907,965 |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | — | 1,021,499 shares | $11,767,668 |
| VERADERMICS INC | COMMON STOCK | 922967104 | — | 95,646 shares | $11,595,165 |
| ENTERA BIO LTD | SHS | M40527109 | — | 3,921,568 shares | $11,411,763 |
| DISC MEDICINE INC | COM | 254604101 | — | 172,709 shares | $11,305,531 |
| ODYSSEY THERAPEUTICS INC | COMMON STOCK | 67613T104 | — | 457,839 shares | $10,173,183 |
| 4D MOLECULAR THERAPEUTICS IN | COM | 35104E100 | — | 684,753 shares | $9,798,815 |
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | — | 601,760 shares | $9,044,453 |
| BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | — | 144,971 shares | $8,698,260 |
| ANNEXON INC | COM | 03589W102 | — | 1,986,806 shares | $8,404,189 |
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | — | 85,614 shares | $8,151,737 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | — | 260,109 shares | $8,133,608 |
| NEKTAR THERAPEUTICS | COM NEW | 640268306 | — | 126,817 shares | $7,678,135 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 211,985 shares | $6,421,026 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 167,716 shares | $5,370,266 |
| KAILERA THERAPEUTICS INC | COMMON STOCK | 482931102 | — | 468,750 shares | $5,353,125 |
| NATERA INC | COM | 632307104 | — | 12,530 shares | $5,178,774 |
| FRACTYL HEALTH INC | COM | 35168W103 | — | 8,841,707 shares | $4,813,425 |
| KARDIGAN INC | COM | 485925101 | — | 312,500 shares | $4,609,375 |
| ELEDON PHARMACEUTICALS INC | COM | 28617K101 | — | 1,637,114 shares | $4,141,898 |
| HEARTFLOW INC | COM | 42238D107 | — | 74,969 shares | $3,729,708 |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | 107924102 | — | 699,532 shares | $2,868,081 |
| KORSANA BIOSCIENCES INC | COM | 23255M303 | — | 87,702 shares | $2,806,464 |
| FREENOME INC | COMMON STOCK | 35661P100 | — | 158,170 shares | $2,491,178 |
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | — | 512,287 shares | $1,562,475 |
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | — | 976,191 shares | $1,190,953 |
| HYPERFINE INC | COM CL A | 44916K106 | — | 1,303,155 shares | $1,052,949 |
| METAGENOMI THERAPEUTICS INC | COM | 59102M104 | — | 528,993 shares | $560,733 |
| FAETH THERAPEUTICS INC | COM NEW | 81728A207 | — | 14,718 shares | $437,713 |
| OUTSET MED INC | COM NEW | 690145206 | — | 107,456 shares | $322,368 |
| ADARX PHARMACEUTICALS INC | COM | 00654F105 | — | 11,357 shares | $226,459 |